Moberg Pharma Q2: Teclara is the clear market leader in both Sweden and Norway - Redeye
Bildkälla: Stockfoto

Moberg Pharma Q2: Teclara is the clear market leader in both Sweden and Norway - Redeye

Q2 confirms that Moberg’s Terclara is now the market leader in both Sweden and Norway. Consumer marketing activities and a strong channel presence have resulted in high market shares of 44% in Sweden (value) and 43% in Norway (value). The H1 2025 success is a good platform ahead of the expanded European Teclara launch in 2026.

Q2 confirms that Moberg’s Terclara is now the market leader in both Sweden and Norway. Consumer marketing activities and a strong channel presence have resulted in high market shares of 44% in Sweden (value) and 43% in Norway (value). The H1 2025 success is a good platform ahead of the expanded European Teclara launch in 2026.
Börsvärldens nyhetsbrev